Roche Holding, headquartered in Basel, Switzerland, is a pioneer in the healthcare industry. Roche is the leading biotech company in the world, with 17 biopharmaceuticals on the market. Biopharmaceuticals make up more than half of the Roche Company's development pipeline, allowing them to provide better-targeted medicines. Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology, and Respiratory Branch Medicines are among their specialties.

Roche is a worldwide leader in medicines and diagnostics dedicated to improving people's lives through science. Roche is the leader in personalised healthcare, a strategy that attempts to match the proper therapy to each patient in the most effective way possible, thanks to the combined powers of pharmaceuticals and diagnostics under one roof.

Roche is the largest biotech firm in the world, offering really unique medications in cancer, immunology, infectious diseases, ophthalmology, and central nervous system illnesses. Roche is also a pioneer in diabetes care and a world leader in in vitro diagnostics and tissue-based cancer diagnostics.

Roche, which was founded in 1896, is still looking for improved methods to prevent, diagnose, and cure illnesses while also contributing to society. By collaborating with all essential parties, the firm also hopes to increase patient access to medical advancements. The World Health Organization Model Lists of Essential Drugs include thirty Roche-developed treatments, including life-saving antibiotics, antimalarials, and cancer medicines. The Dow Jones Sustainability Indices have named Roche the Group Leader in Sustainability in the Pharmaceuticals, Biotechnology, and Life Sciences Industry for the tenth year in a row (DJSI).

Founded: 1896

Headquarters: Basel, Switzerland

Market Cap: 350.650 Billion USD

Website: https://www.roche.com/

Novartis is a multinational healthcare and pharmaceutical corporation headquartered in Switzerland. Novartis focuses on patented pharmaceuticals, generic medications, and eye care — categories in which they have the requisite innovative capability and global size to compete effectively. At the same time, Novartis is extending its footprint in emerging areas such as Asia, Africa, and Latin America, where the demand for high-quality pharmaceuticals and healthcare is rapidly growing. As of 2019, they employ approximately 103,000 people throughout the world.

Novartis is redefining medicine in order to help people live longer, healthier lives. As a prominent global pharmaceuticals company, it leverages breakthrough science and digital technologies to produce transformative solutions in areas of severe medical need. In their quest to find new treatments, they consistently rank among the world's top firms in terms of research and development investment. Novartis' medicines are used by about 1 billion people throughout the world, and the firm is always seeking for innovative ways to increase access to its newest treatments. Novartis employs more than 125 000 people from more than 140 different countries all over the world.

Novartis is well known for being one of the largest pharmaceutical companies in the world, but it also makes and sells medical technologies. In 2019, the Concept1 inhaler became the first device of any kind to be certified under the new MDR standards of the European Union. (Regulation of Medical Devices)

Founded: December 1996

Novo Nordisk is a multinational pharmaceutical company established in Denmark. Novo Nordisk is a worldwide healthcare firm with over 90 years of diabetes care innovation and leadership. Novo Nordisk, headquartered in Denmark, employs roughly 41,600 people in 79 countries and sells its medicines in over 170 countries as of 2019.

Their mission is to inspire change in the fight against diabetes and other significant chronic diseases including obesity, as well as uncommon blood and endocrine abnormalities. They do so through breaking new ground in science, increasing access to their medications, and trying to prevent and eventually cure disease.

Novo Nordisk employs around 47,000 employees in 80 countries and sells its products in over 170. Annual Revenues are 122,021 million DKK and Net Income is 38,951 million DKK as of December 2019.

Founded: December 21, 1923

AstraZeneca is a pharmaceutical and biotechnology company based in the United Kingdom. In the battle against COVID-19, Astrazeneca is one of the top five companies in the world, and they are beginning Phase III studies in conjunction with the University of Oxford.

Their mission is to push science's frontiers in order to develop life-changing treatments. They think that putting research at the core of all they do is the greatest approach to achieve their Purpose. They are defined by science. It is part of our DNA and why they come to work every day. This, however, is only half of the tale. They are well aware that they do not possess all of the solutions. They want to share their thoughts because they feel it will lead to improved treatments. They aim to operate in a way that is welcoming, open, and collaborative. This mindset pervades all they do.

They are selectively active in the areas of autoimmune, neurology, and infection, and focus on three key therapeutic areas: oncology, cardiovascular and metabolic disease (CVMD), and respiratory disease. They want to use our mix of strengths, which include small molecules and biologics, immunotherapies, and inventing new delivery systems that provide patients a choice, to put us in the greatest position to push the limits of science. These are bolstered by a significant focus on customized healthcare capabilities, which try to match medications to just those patients who would benefit. Their teams also collaborate with some of the world's most prestigious academic and biotech research institutes to foster innovation and assess new technologies like modified RNA and CRISPR genome editing.

Founded: April 6, 1999
Market Cap: 181.450 Billion USD

Headquarters: Cambridge, United Kingdom

Website: https://www.astrazeneca-us.com/

Sanofi is a worldwide life sciences business dedicated to enhancing healthcare access and supporting the people we serve across the healthcare continuum. Sanofi develops healthcare solutions in human vaccines, rare illnesses, multiple sclerosis, cancer, immunology, infectious diseases, diabetes, and cardiovascular solutions, as well as consumer healthcare, from prevention to treatment. Sanofi employs almost 110,000 individuals who are committed to making a difference in patients' lives, no matter where they reside, by enabling them to live a healthy life.

Sanofi employs 100,409 people across 100 countries as of 2019. In 2019, Sanofi spent 6,022 million euros on research and development. Sanofi has 32 production facilities spread across 32 nations. Sanofi is a global healthcare company with operations in more than 170 countries.

Founded: 2004

Headquarters: Paris, France

Market Cap: 130.900 Billion USD

Website: https://www.sanofi.com/

GlaxoSmithKline is a multi-national pharmaceuticals company located in the United Kingdom with a diverse range of new and old drugs. GSK is actively working on novel medications in the areas of respiratory, HIV, cancer, and immuno-inflammation, with an R&D strategy centered on immune system research, genetics, and innovative technology. The company's headquarters are in the United Kingdom.

A science-driven global healthcare firm with a unique mission: to enable people to achieve more, feel better, and live longer. They operate three worldwide companies that develop, manufacture, and market new pharmaceutical medications, vaccines, and consumer healthcare products.

With our three worldwide companies, scientific and technological know-how, and brilliant people, they aspire to offer distinctive, high-quality, and required healthcare goods to as many people as possible.

Everyone at GSK is focused on three long-term goals: innovation, performance, and trust, all of which are supported by a desire to create a more purposeful and performance-driven culture that is in line with their values.

Founded: December 2000

Headquarters: Brentford, United Kingdom

Market Cap: 102.500 Billion USD

Website: https://www.gsk.com/en-gb/home/

Allergan plc is an American pharmaceutical business with its headquarters in Dublin, Ireland. It buys, develops, produces, and markets brand-name pharmaceuticals and medical devices in the fields of medical aesthetics, eye care, central nervous system, and gastroenterology. Botox is manufactured by this business. As of 2019, Allergan employs 17,400 people in over 100 countries.

Allergan is dedicated to discovering, manufacturing, and marketing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products for people all over the world. Abbvie Inc, headquartered in Illinois, USA, has bought Allergan.

AbbVie's aim is to find and deliver new medicines that address today's medical concerns as well as those that will arise in the future. They aim to make a significant difference in people's lives via immunology, cancer, neurology, eye care, virology, women's health, and gastroenterology, as well as goods and services under the Allergan Aesthetics portfolio.

Founded: 1983

Headquarters: Clonshaugh Business & Technology Park, Coolock, D17 E400, Dublin, Ireland

Market Cap: 63.65 Billion USD

Website: https://www.abbvie.com/

Merck is a multinational healthcare and pharmaceutical corporation headquartered in the United States. Merck Company's breakthrough medicines, vaccines, and animal health products make a difference in people's lives all around the world.

They develop novel approaches to cure the most difficult diseases, such as multiple sclerosis and cancer, in healthcare. Their Life Science professionals assist scientists by building tools and solutions that aid in the faster delivery of discoveries. They also produce research that lies within technology and transforms the way we access, store, process, and display information in Electronics.

Everything they do is motivated by a belief in the positive power of science and technology. Since 1668, this conviction has guided our work and will continue to motivate us to develop more happy and sustainable ways of life.

Founded: 1668

The Lonza Group is a Swiss multinational chemicals and biotechnology corporation with large operations in Europe, North America, and South Asia. It is headquartered in Basel. Lonza was founded in Switzerland in the late 1800s under that name. Organic, fine, and performance chemicals, bespoke manufacture of biopharmaceuticals, chemical synthesis capabilities, detection systems, and services for the bioscience sector are among the company's product development services for the pharmaceutical and biologic sectors.

Lonza makes #AHealthierWorld possible by assisting healthcare customers on the road to commercialization. Their 15,000 brilliant workers operate across a global network of more than 30 facilities to meet the needs of our clients in the pharmaceutical, biotechnology, and nutrition industries.

They assist clients produce novel and innovative medications that help cure a wide range of ailments by combining technology insight with world-class production, scientific understanding, and process excellence. They work in science, but there isn't a magic formula for how they do it. Talented individuals working together, generating commitment and ideas that assist their clients benefit others, is their most scientific answer.

Founded: 1897

Headquarters: Basel

Market Cap: 61.909 Billion USD

Website: https://www.lonza.com/

Grifols is a multinational healthcare firm that has worked to promote the health and well-being of people all over the world since its founding in Barcelona in 1909. In more than 100 countries and territories, our four businesses - Bioscience, Diagnostics, Hospital, and Bio Supplies - create, produce, and sell new medicines, solutions, and services.

They are one of the major plasma firms, with a growing network of donation sites throughout the world, as a pioneer in the blood products market. They make important medications using the plasma they collect to treat chronic, uncommon, and sometimes life-threatening disorders. They have a complete array of products designed to assure safety from donor to transfusion as a recognized leader in transfusion medicine. They also give diagnostic instruments and services to hospitals, pharmacies, and healthcare professionals to aid in the identification and treatment of illnesses, fostering specialized and efficient care.

Grifols is devoted to a sustainable business strategy and is a pioneer in continuous innovation, quality, safety, and ethical leadership in the healthcare industry, with over 24,000 people in more than 30 countries and regions. Their activities have a good social and economic impact in the nations where they operate, resulting in the creation of employment and money.

Founded: November 18, 1940

Headquarters: Barcelona, Spain
Market Cap: 14.181 Billion USD
Website: https://www.grifols.com/en/home